Cite
APA Citation
Leleu, X., Chari, A., Richard, S., Khurana, M., Yusuf, A., & Usmani, S. Z. (2021). a combination of carfilzomib, dexamethasone, and daratumumab for treatment of adult patients with relapsed/refractory multiple myeloma in two dosing regimens: once-weekly and twice-weekly. Expert review of hematology, 14(12), 1049–1058. http://access.bl.uk/ark:/81055/vdc_100148638465.0x00000a